Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Ovarian Neoplasms × Biosimilar Pharmaceuticals × Clear all

Phase

Status

Recruiting 3 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Ovarian Neoplasms 1

Interventions

Bevacizumab 8 Paclitaxel 6 fluzoparib 5 Carboplatin 5 olaparib 3 famitinib 2 apatinib 2 Topotecan 2 Oxaliplatin 2 Drug Therapy 2 Cisplatin 2 trastuzumab deruxtecan 1 trametinib 1 niraparib 1 montelukast 1 liposomal doxorubicin 1 fludarabine 1 durvalumab 1 dalpiciclib 1 dabrafenib 1 ceralasertib 1 bemarituzumab 1 aldesleukin 1 Ultrasonography, Doppler 1 Therapeutics 1 Tablets 1 Surgical Procedures, Operative 1 Sensitivity Training Groups 1 Saline Solution 1 SHR-1701 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06650709 2024-10-23

NEOCATS

British Columbia Cancer Agency

Phase 2 Not yet recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡